There are a number of growth drivers across the digestives space, starting with the biggest proton-pump inhibitor to make its way from behind the pharmacy bench to over-the-counter aisles since the original “Purple Pill” was switched in 2003.
The generic drug industry — and by extension, patients across the United States — is being adversely impacted by what some are calling branded drug makers’ abuse of risk evaluation and mitigation strategies, or REMS.
Food and drug retailers may need to modify their approaches to get the most from their general merchandise outside of the big fourth-quarter holidays, according to a new whitepaper from the Global Marketing Development Center. The report is the second part of GMDC’s “Seasonal Best Practices for the New World of Shopping” series.
Since they debuted early last year, Frito-Lay’s Cheetos Mix-Ups have caught consumers’ attention and recorded phenomenal sales growth. IRI data shows that sales of the snack mix increased by more than 163% during the 12 months ended June 15.
Alexa Health Products’ FruitChia bars have garnered a great deal of attention over the past year. Made with only two ingredients — fruit and chia seeds — the naturally sweetened, gluten-free bars provide a mixture of antioxidants, dietary fiber, and omega-3 and omega-6 essential fatty acids.
While public health officials and the media continue to trumpet how many Americans’ eating habits can adversely affect their health, consumers do not yet seem ready to swear off traditional snack foods in favor of more healthy options.